Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric VTE trial of edoxaban versus standard anticoagulant therapy
2016-000991-49Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in venous thromboembolism (VTE) comparing Edoxaban with Standard of care anticoagulant therapy (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2016; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2016-000991-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000991-49.